Department of Work and Social Psychology, Maastricht University, Maastricht, the Netherlands.
Transgender Netwerk Nederland, Amsterdam, the Netherlands.
Euro Surveill. 2024 Nov;29(48). doi: 10.2807/1560-7917.ES.2024.29.48.2400347.
BackgroundGlobal data highlight the disproportionate burden of HIV and sexually transmitted infections (STIs) among transgender individuals. However, scant data exist for both transgender and non-binary individuals in European HIV/STI surveillance.AimTo assess self-reported prevalence of HIV and bacterial STIs (syphilis, gonorrhoea, chlamydia) in the past 6 months among transgender and non-binary individuals, comparing the likelihoods of recent STIs between groups.MethodsUsing data from the cross-sectional PROTECT survey conducted in 20 European countries from October 2023 to April 2024, we analysed a subset of 452 participants, 178 transgender and 274 non-binary individuals. Logistic regression was used to compare the risk of each recent bacterial STI, and Poisson regression to compare the risk of the number of recent STIs.ResultsAmong transgender individuals, 5 (2.8%) self-reported HIV infection, and recent STI prevalence was 6.7% for syphilis, 15.6% for gonorrhoea and 19.6% for chlamydia. For non-binary individuals, 15 (5.5%) self-reported HIV infection and recent STI prevalence was 15.0% for syphilis, 18.7% for gonorrhoea and 20.8% for chlamydia. Non-binary individuals had significantly higher risk for syphilis (aOR: 1.81; 95% CI: 1.01-4.05) and multiple recent STIs (aOR: 1.46; 95% CI: 1.11-1.91) compared with transgender individuals.ConclusionWhile both transgender and non-binary individuals showed high self-reported prevalence of HIV and bacterial STIs, non-binary individuals showed greater prevalence of STIs, particularly syphilis. Efforts aimed at HIV/STI prevention and surveillance should encourage inclusion of those who identify as non-binary and other gender-diverse individuals alongside transgender individuals to enhance the provision of tailored prevention and treatment services in Europe.
背景
全球数据突出显示，跨性别者和非二元性别者感染艾滋病毒和性传播感染（STIs）的负担不成比例。然而，在欧洲艾滋病毒/性传播感染监测中，针对跨性别者和非二元性别者的相关数据却很少。
目的
评估过去 6 个月内跨性别者和非二元性别者自我报告的艾滋病毒和细菌性 STIs（梅毒、淋病、衣原体）的流行率，并比较两组人群中最近 STIs 的发生概率。
方法
我们使用 2023 年 10 月至 2024 年 4 月在 20 个欧洲国家进行的横断面 PROTECT 调查的数据，分析了 452 名参与者中的一个子集，其中 178 名为跨性别者，274 名为非二元性别者。采用逻辑回归比较了每种最近细菌性 STI 的风险，采用泊松回归比较了最近 STIs 数量的风险。
结果
在跨性别者中，有 5 人（2.8%）自我报告感染艾滋病毒，梅毒、淋病和衣原体的最近 STIs 流行率分别为 6.7%、15.6%和 19.6%。而非二元性别者中，有 15 人（5.5%）自我报告感染艾滋病毒，梅毒、淋病和衣原体的最近 STIs 流行率分别为 15.0%、18.7%和 20.8%。与跨性别者相比，非二元性别者梅毒（优势比[OR]：1.81；95%置信区间[CI]：1.01-4.05）和多种最近 STIs（OR：1.46；95%CI：1.11-1.91）的风险更高。
结论
尽管跨性别者和非二元性别者都表现出较高的自我报告艾滋病毒和细菌性 STIs 流行率，但非二元性别者的 STIs 流行率更高，尤其是梅毒。旨在预防艾滋病毒/性传播感染和监测的努力应鼓励包括那些自我认同为非二元性别者和其他性别多样化者在内的跨性别者，以增强在欧洲提供针对性预防和治疗服务的能力。
